Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.
Relugolix safely alleviates menstrual and non-menstrual pelvic pain in women with endometriosis when administered once-a-day in combination with estradiol and progestin, data from a Phase 3 trial show. “The clinically-meaningful ... Read more
Tiny particles, or nanoparticles, containing a special fluorescent dye that labels and eliminates lesions caused by endometriosis can be used to alleviate pain and fertility issues associated with the ... Read more
Stem cells responsible for repairing the womb following menstruation can also promote endometriosis and endometrial cancer if they become dysfunctional, researchers have found. Such malfunctioning stem cells also can ... Read more
Myovant Sciences has completed patient recruitment for its ongoing Phase 3 SPIRIT 1 clinical trial assessing the safety and effectiveness of relugolix in combination with estradiol and progestin to ... Read more
Predictive Laboratories has begun to commercialize PGxPLUS+, a test developed to assess the effect of genetic factors in the way a patient responds to pain medications, for people living with endometriosis, ... Read more
DotLab has secured $10 million in Series A funding that will be used to drive the development of DotEndo, its proprietary noninvasive diagnostic test for endometriosis. “The revolutionary technology ... Read more